USPTO serial 78711010
VITROGRO
Reviewed by CopyMark Law Group
Reg. 3492641Status 710
- Filing date
- Status date
- Registration date
- Aug 26, 2008
- Examiner
- KIM, YONG OH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with VITROGRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James H. Walters
JAMES H. WALTERS patenttm.usPO Box 82788Portland, OR 97282-0788UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in science and industry, namely, tissue culture media preparations; biological products for use in science and industry, namely, a 3-dimensional living skin model comprising a de-cellurized de-epidermized dermis prepared from donor skin, used for investigating wound healing, pharmaceutics, toxicology, drug sensitivity, drug penetration and drug delivery, and recombinant therapeutic proteins for medical treatments; biochemical products, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factors and formulations consisting of one or more of the foregoing proteins or chimeric protein containing any combination of the foregoing proteins or part thereof for use in science and industry for cell culture and tissue engineering research, and manufacturing of vaccines, proteins and bio-pharmaceuticals; kits containing biochemicals, namely, cell culture kits used for research; biochemicals used for cell culture and tissue engineering research and for use in the clinical manufacture of vaccines, proteins, bio-pharmaceuticals, preparations for wound treatments, cell cultures and wound dressings; reagents and recombinant proteins for scientific and research use; chemical preparations for cell culture for scientific and research use; biochemical reagents for scientific and research use; chemical reagents for scientific and research use | SECTION 8 - CANCELLED | — |
| 005 | Biological preparations, namely, spray-on skin and cultured skin grafts for burn treatment and reconstructive ophthalmic or bladder surgeries, and recombinant therapeutic proteins for medical treatment of burns, hard to heal wounds, surgically created wounds, and incisions; pharmaceutical preparations for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries; veterinary preparations for horses, cattle, pigs, cats and dogs for treating burns and venous ulcers, wounds in diabetics, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries; chemical preparations for cell culture for medical purposes; chemical reagents for medical use; biochemical reagents for medical use; recombinant proteins for medical use; growth factor preparations, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factor and formulations comprising one or more of the foregoing proteins or chimeric protein for use in cell culture autologous treatments, and for the treatment of burn and venous ulcer wounds, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after surgery; tissue culture media used for medical purposes; pharmaceutical preparations for skin care used for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries, and for improving the appearance of wrinkles and skin defects; medical dressings, surgical dressings, wound care components, namely wound and surgical dressings; healing components, namely, vitronectin, fibronectin, insulin-like growth factor-I, insulin-like growth factor II, insulin-like growth factor binding proteins, epidermal growth factor, fibroblast growth factor, formulations comprising of one or more of the foregoing proteins or chimeric proteins for use in treatment of burns, diabetic and venous ulcers, and to improve healing after ophthalmic and cosmetic surgery; surgical implants, namely, arterial grafts; implant coatings to encourage healing and incorporation of an implant into the surrounding tissue bed; implant coatings for use in treatment of arthrosclerosis and the treatment of cancer; drugs for medical purposes for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and cosmetic surgeries, and for use with cells and tissue for transplantation, targeted delivery of drugs and bio-pharmaceuticals and for treatment of cancer; drugs for veterinary purposes for use on horses, cattle, pigs, cats or dogs for treating burns, venous ulcers, diabetic wounds, non-diabetic chronic wounds, surgical wounds, and to speed healing and improve recovery and scarring after ophthalmic and excisional surgeries, and for use with cells and tissue for transplantation, targeted delivery of drugs and bio-pharmaceuticals and for treatment of cancer; and vaccines | SECTION 8 - CANCELLED | — |
| 009 | Glassware for scientific experiments in laboratories; laboratory glassware; cell culture apparatus and related consumable items, namely, tissue culture flasks and multi-welled cell culture plates; bio-reactors, cell farms, culture bags and blood bags, all for cell culturing for industrial, medical or research purposes; bio-reactors, cell farms, culture bags and blood bags, all for cultivation of adherent and non-adherent cells for industrial, medical or research purposes; cell culture apparatus and related disposable items, namely, tissue culture flasks and multi-welled cell culture plates; cell culture apparatus and related disposable items for use in cultivation of adherent and non-adherent cells for industrial, medical or research purposes, namely, bio-reactors, cell farms, culture bags and blood bags; laboratory equipment, namely, flasks, plates, and petri dishes | SECTION 8 - CANCELLED | — |
| 010 | Surgical implants, namely, coated stents, cardiac pacemakers, artificial joints, inter-osseous nails, screws and fixation devices | SECTION 8 - CANCELLED | — |
| 042 | Scientific services, namely, using a 3-dimensional living skin model for testing irritation and sensitivity of topical pharmaceuticals, cosmetics, and medical devices, in vitro efficacy testing of topical wound healing treatments and medical devices for others; technological services, namely, using a 3-dimensional living skin model for developing and identifying cell culture media formulations suitable for industrial cell culture, research or medical use; laboratory research services in the field of pharmaceutical research such as drug discovery, formulation and delivery | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tissue Therapies Limited
- Other trademarks owned by Tissue Therapies Limited
- Other trademarks owned by Tissue Therapies Limited
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named VITROGRO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 27, 2015 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 1, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 26, 2008 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 10, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 21, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| May 8, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 8, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| May 7, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 7, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 7, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 19, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 15, 2007 | ALIE | ASSIGNED TO LIE | — |
| Oct 16, 2007 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Oct 16, 2007 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Oct 16, 2007 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Oct 16, 2007 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Apr 16, 2007 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 15, 2007 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 2, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 29, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 29, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 31, 2006 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 30, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 22, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2005 | NWAP | NEW APPLICATION ENTERED | — |